| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 1995 Oxford University Press
OTHER |
A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia
1Departments of Pediatrics, Georgetown University Medical Center Washington, D.C. 20007 2Departments of Cell Biology and Biochemistry, Georgetown University Medical Center Washington, D.C. 20007 3Department of Obstetrics and Gynecology, Stanford University Medical Center Stanford, CA 94305 4Developmental Endocrinology Branch NICHD, NIH, Bethesda, MD 20892 5Department of Internal Medicine, University of Texas, Southwestern Medical Center Dallas TX 75235, USA 6Great Ormond Street Hospital for Children and Guy's Hospital London, UK
*To whom correspondence should be addressed
Received April 17, 1995; Revised May 9, 1995; Accepted May 9, 1995
Leydig cell hypoplasia (LCH) is a form of male pseudohermaphroditism in which Leydig cell differentiation and testosterone production are impaired. This report describes the first case of a nonsense mutation (A1635C) in exon 11 of the human luteinizing hormone receptor (hLHR) gene in two sisters with LCH. This mutation causes loss of function of the receptor by introducing a stop codon at residue 545 in transmembrane helix 5 of the hLHR. Surface expression of the truncated hLHR (hLHR-t545) in human embryonic kidney cells stably transfected with cDNA encoding hLHR-t545 was diminished compared to the wild-type hLHR and hCG-induced cAMP accumulation was impaired. These results establish that single base mutations in exon 11 of the hLHR gene can produce inactivation as well as activation of the hLHR. Furthermore, they demonstrate that functional domains between transmembrane helix 5 and the C-terminal cytoplasmic tail of the hLHR are required for normal cell surface expression of the receptor and signal transduction.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Y.-K. Leung, P. J. Steinbach, D. Bear, V. Baxendale, P. Y. Fechner, O. M. Rennert, and W.-Y. Chan Biological Effect of a Novel Mutation in the Third Leucine-Rich Repeat of Human Luteinizing Hormone Receptor Mol. Endocrinol., October 1, 2006; 20(10): 2493 - 2503. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Richter-Unruh, E Korsch, O Hiort, P M Holterhus, A P Themmen, and S A Wudy Novel insertion frameshift mutation of the LH receptor gene: problematic clinical distinction of Leydig cell hypoplasia from enzyme defects primarily affecting testosterone biosynthesis Eur. J. Endocrinol., February 1, 2005; 152(2): 255 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
A L Ogilvy-Stuart and C E Brain Early assessment of ambiguous genitalia Arch. Dis. Child., May 1, 2004; 89(5): 401 - 407. [Full Text] [PDF] |
||||
![]() |
L. Abdennebi, E. Y. Chun, H. Jammes, D. Wei, and J. J. Remy Maintenance of Sexual Immaturity in Male Mice and Bucks by Immunization Against N-Terminal Peptides of the Follicle-Stimulating Hormone Receptor Biol Reprod, January 1, 2003; 68(1): 323 - 327. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. N. Kalantaridou and G. P. Chrousos Monogenic Disorders of Puberty J. Clin. Endocrinol. Metab., June 1, 2002; 87(6): 2481 - 2494. [Full Text] [PDF] |
||||
![]() |
M. Ascoli, F. Fanelli, and D. L. Segaloff The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective Endocr. Rev., April 1, 2002; 23(2): 141 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. N. Themmen and I. T. Huhtaniemi Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function Endocr. Rev., October 1, 2000; 21(5): 551 - 583. [Abstract] [Full Text] |
||||
![]() |
J. C. Zenteno, P. Canto, S. Kofman-Alfaro, and J. P. Mendez Evidence for Genetic Heterogeneity in Male Pseudohermaphroditism due to Leydig Cell Hypoplasia J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3803 - 3806. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-M. Wu, K. M. Hallermeier, L. Laue, C. Brain, A. C. Berry, D. B. Grant, J. E. Griffin, J. D. Wilson, G. B. Cutler Jr., and W.-Y. Chan Inactivation of the Luteinizing Hormone/Chorionic Gonadotropin Receptor by an Insertional Mutation in Leydig Cell Hypoplasia Mol. Endocrinol., November 1, 1998; 12(11): 1651 - 1660. [Abstract] [Full Text] |
||||
![]() |
M. Phillip, J. E. Arbelle, Y. Segev, and R. Parvari Male Hypogonadism Due to a Mutation in the Gene for the {beta}-Subunit of Follicle-Stimulating Hormone N. Engl. J. Med., June 11, 1998; 338(24): 1729 - 1732. [Full Text] [PDF] |
||||
![]() |
J. W. M. Martens, M. Verhoef-Post, N. Abelin, M. Ezabella, S. P. A. Toledo, H. G. Brunner, and A. P. N. Themmen A Homozygous Mutation in the Luteinizing Hormone Receptor Causes Partial Leydig Cell Hypoplasia: Correlation between Receptor Activity and Phenotype Mol. Endocrinol., June 1, 1998; 12(6): 775 - 784. [Abstract] [Full Text] |
||||
![]() |
T. G. Rozell, D. P. Davis, Y. Chai, and D. L. Segaloff Association of Gonadotropin Receptor Precursors with the Protein Folding Chaperone Calnexin Endocrinology, April 1, 1998; 139(4): 1588 - 1593. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Latronico, Y. Chai, I. J.P. Arnhold, X. Liu, B. B. Mendonca, and D. L. Segaloff A Homozygous Microdeletion in Helix 7 of the Luteinizing Hormone Receptor Associated with Familial Testicular and Ovarian Resistance Is Due to Both Decreased Cell Surface Expression and Impaired Effector Activation by the Cell Surface Receptor Mol. Endocrinol., March 1, 1998; 12(3): 442 - 450. [Abstract] [Full Text] |
||||
![]() |
Y. Osuga, M. Hayashi, M. Kudo, M. Conti, B. Kobilka, and A. J. W. Hsueh Co-expression of Defective Luteinizing Hormone Receptor Fragments Partially Reconstitutes Ligand-induced Signal Generation J. Biol. Chem., October 3, 1997; 272(40): 25006 - 25012. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Layman, E.-J. Lee, D. B. Peak, A. B. Namnoum, K. V. Vu, B. L. van Lingen, M. R. Gray, P. G. McDonough, R. H. Reindollar, and J. L. Jameson Delayed Puberty and Hypogonadism Caused by Mutations in the Follicle-Stimulating Hormone {beta}-Subunit Gene N. Engl. J. Med., August 28, 1997; 337(9): 607 - 611. [Full Text] [PDF] |
||||
![]() |
M. Misrahi, G. Meduri, S. Pissard, C. Bouvattier, I. Beau, H. Loosfelt, A. Jolivet, R. Rappaport, E. Milgrom, and P. Bougneres Comparison of Immunocytochemical and Molecular Features with the Phenotype in a Case of Incomplete Male Pseudohermaphroditism Associated with a Mutation of the Luteinizing Hormone Receptor J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2159 - 2165. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-P. Zhang, A. S. Rannikko, P. R. Manna, H. M. Fraser, and I. T. Huhtaniemi Cloning and Functional Expression of the Luteinizing Hormone Receptor Complementary Deoxyribonucleic Acid from the Marmoset Monkey Testis: Absence of Sequences Encoding Exon 10 in Other Species Endocrinology, June 1, 1997; 138(6): 2481 - 2490. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. W. Heymann and S. Subramaniam Expression, stability, and membrane integration of truncation mutants of bovine rhodopsin PNAS, May 13, 1997; 94(10): 4966 - 4971. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Jaquette and D. L. Segaloff Temperature Sensitivity of Some Mutants of the Lutropin/Choriogonadotropin Receptor Endocrinology, January 1, 1997; 138(1): 85 - 91. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Gilchrist, K.-S. Ryu, I. Ji, and T. H. Ji The Luteinizing Hormone/Chorionic Gonadotropin Receptor Has Distinct Transmembrane Conductors for cAMP and Inositol Phosphate Signals J. Biol. Chem., August 9, 1996; 271(32): 19283 - 19287. [Abstract] [Full Text] [PDF] |
||||









